Skip to main content
. Author manuscript; available in PMC: 2015 May 25.
Published in final edited form as: Mol Cell Endocrinol. 2014 Feb 6;389(0):84–91. doi: 10.1016/j.mce.2013.12.019

Fig. 4. Effectiveness of aromatase antisense oligodeoxynucleotide (AS-ODN) knockdown in reducing brain-derived E2 levels in the hippocampal CA1 region at 3 days post global cerebral ischemia (GCI) reperfusion.

Fig. 4

(A) E2 levels in the indicated groups were measured by a specific E2 ELISA using protein samples from hippocampal CA1 region at 3 days post GCI reperfusion. Data were expressed as mean ± SE from 4–5 rats per group. *P<0.05 vs. sham, #P<0.05 vs. MS group. N=3–5. (B) Representative confocal images showing the reduction of brain-derived E2 levels in CA1 region astrocytes at 3 days after GCI reperfusion (Magnification: ×40, Scale bar = 50 μm).